Brief

The document provides guidance on reporting adverse incidents related to intraocular lenses (IOLs). It emphasizes the importance of timely and accurate reporting, particularly when a medical device vigilance system is in place. The guidelines outline procedures for reporting incidents, including serious adverse events, device failures, and unexpected adverse effects. Reporting is essential to ensure public safety and to improve IOL design and performance. This guidance should be read alongside MEDDEV 2.12/1, the guidelines on a medical devices vigilance system.

This content is restricted.

Highlights content goes here...

This content is restricted.

Medicines and Healthcare products Regulatory Agency (MHRA)

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.
Individual Plan
$125 / month OR $1250 / year
Features
Best for: Researchers, Legal professionals, Academics
Enterprise Plan
Contact for Pricing
Features
Best for: Law Firms, Corporations, Government Bodies